Leucemia (Italian Wikipedia)

Analysis of information sources in references of the Wikipedia article "Leucemia" in Italian language version.

refsWebsite

Global rank Italian rank

13nih.gov

4^th place

9^th place

12web.archive.org

1^st place

9doi.org

2^nd place

7^th place

8cancer.gov

1,684^th place

2,574^th place

5oadoi.org

799^th place

22^nd place

4archive.org

6^th place

8^th place

2cancer.org

3,680^th place

8,916^th place

2who.int

195^th place

342^nd place

2medscape.com

719^th place

799^th place

1educom.it

low place

1comitatomarialetiziaverga.it

low place

1leukemia-lymphoma.org

low place

1lls.org

low place

1novartisoncology.com

low place

1cancerconsultants.com

low place

1moffitt.org

low place

1books.google.com

3^rd place

14^th place

1ebscohost.com

1,786^th place

3,409^th place

1jmmlfoundation.org

low place

archive.org

World Cancer Report 2014., World Health Organization, 2014, pp. Chapter 5.13, ISBN 92-832-0429-8.
World Cancer Report 2014., World Health Organization, 2014, pp. Chapter 5.13, ISBN 92-832-0429-8.
Colvin G. A., Elfenbein G. J., The latest treatment advances for acute myelogenous leukemia, in Medicine and Health, Rhode Island, vol. 86, n. 8, 2003, pp. 243–6, PMID 14582219.
Colvin GA, Elfenbein GJ, The latest treatment advances for acute myelogenous leukemia, in Med Health R I, vol. 86, n. 8, 2003, pp. 243–6, PMID 14582219.

books.google.com

Elaine Sarkin Jaffe, Nancy Lee Harris, World Health Organization, International Agency for Research on Cancer, Harald Stein, J. W. Vardiman, Pathology and genetics of tumours of haematopoietic and lymphoid tissues, World Health Organization Classification of Tumors, vol. 3, Lyon, IARC Press, 2001, ISBN 92-832-2411-6.

cancer.gov

Leukemia, su NCI. URL consultato il 13 giugno 2014.
What You Need To Know About™ Leukemia, su National Cancer Institute, 23 dicembre 2013. URL consultato il 18 giugno 2014.
A Snapshot of Leukemia, su NCI. URL consultato il 18 giugno 2014.
National Cancer Institute, Chronic Lymphocytic Leukemia (PDQ) Treatment: Stage Information, su cancer.gov. URL consultato il 4 settembre 2007.

seer.cancer.gov

SEER Stat Fact Sheets: Leukemia, su seer.cancer.gov, National Cancer Institute, 2011.
Horner MJ, Ries LAG, Krapcho M, Neyman N, et al. (eds)., SEER Cancer Statistics Review, 1975–2006, su Surveillance Epidemiology and End Results (SEER), Bethesda, MD, National Cancer Institute. URL consultato il 3 novembre 2009.
«Table 1.4: Age-Adjusted SEER Incidence and U.S. Death Rates and 5-Year Relative Survival Rates By Primary Cancer Site, Sex and Time Period»
James G. Gurney, Malcolm A. Smith, Julie A. Ross (1999) Cancer Incidence and Survival among Children and Adolescents, United States SEER program 1975–1995, chapter on Leukemia Cancer Statistics Branch, National Cancer Institute, available online from the SEER web site
Finding Cancer Statistics » Cancer Stat Fact Sheets »Chronic Lymphocytic Leukemia National Cancer Institute.

cancer.org

American Cancer Society, Survival rates for childhood leukemia, su cancer.org, 2 marzo 2014.
American Cancer Society, Typical treatment of acute myeloid leukemia (except promyelocytic M3), su Detailed Guide: Leukemia – Acute Myeloid (AML), American Cancer Society, 22 marzo 2012. URL consultato il 31 ottobre 2012.

cancerconsultants.com

professional.cancerconsultants.com

Updated Results of Tyrosine Kinase Inhibitors in CML Archiviato il 29 dicembre 2007 in Internet Archive. ASCO 2006 Conference Summaries.

comitatomarialetiziaverga.it

Educom srl, http://www.educom.it/, Il Dolore « Capire la malattia | Comitato Maria Letizia Verga, su Comitato Maria Letizia Verga. URL consultato il 23 dicembre 2017.

doi.org

dx.doi.org

JW Vardiman, J Thiele, DA Arber, RD Brunning, MJ Borowitz, A Porwit, NL Harris, MM Le Beau, E Hellström-Lindberg, A Tefferi e CD Bloomfield, The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes., in Blood, vol. 114, n. 5, 30 luglio 2009, pp. 937–51, DOI:10.1182/blood-2009-03-209262, PMID 19357394.
JJ Hutter, Childhood leukemia., in Pediatrics in review / American Academy of Pediatrics, vol. 31, n. 6, Jun 2010, pp. 234–41, DOI:10.1542/pir.31-6-234, PMID 20516235.
R Lozano, M, K, S, K, V, J, T, R, SY, M, HR, LM, KG, C, LM, S, DH, ML, EJ, D, K, B, A, G, F, I, S, C e M0, Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010, in Lancet, vol. 380, n. 9859, 15 dicembre 2012, pp. 2095–128, DOI:10.1016/S0140-6736(12)61728-0, PMID 23245604.
Joseph Wiemels, Perspectives on the Causes of Childhood Leukemia, in Chemico-biological interactions, vol. 196, n. 3, 5 aprile 2012, DOI:10.1016/j.cbi.2012.01.007. URL consultato il 23 dicembre 2017.
Else, M., Ruchlemer, R., Osuji, N., Long remissions in hairy cell leukemia with purine analogs: a report of 219 patients with a median follow-up of 12.5 years, in Cancer, vol. 104, n. 11, 2005, pp. 2442–8, DOI:10.1002/cncr.21447, PMID 16245328.
Valbuena JR, Herling M, Admirand JH, Padula A, Jones D, Medeiros LJ, T-cell prolymphocytic leukemia involving extramedullary sites, in American Journal of Clinical Pathology, vol. 123, n. 3, marzo 2005, pp. 456–64, DOI:10.1309/93P4-2RNG-5XBG-3KBE, PMID 15716243.
Eichhorst BF, Busch R, Hopfinger G, Pasold R, Hensel M, Steinbrecher C, Siehl S, Jäger U, Bergmann M, Stilgenbauer S, Schweighofer C, Wendtner CM, Döhner H, Brittinger G, Emmerich B, Hallek M, German CLL Study Group, Fludarabine plus cyclophosphamide versus fludarabine alone in first-line therapy of younger patients with chronic lymphocytic leukemia, in Blood, vol. 107, n. 3, 2006, pp. 885–91, DOI:10.1182/blood-2005-06-2395, PMID 16219797.
Gribben JG, Stem cell transplantation in chronic lymphocytic leukemia, in Biol. Blood Marrow Transplant., vol. 15, 1 Suppl, gennaio 2008, pp. 53–8, DOI:10.1016/j.bbmt.2008.10.022, PMC 2668540, PMID 19147079.
Dearden CE, Matutes E, Cazin B, High remission rate in T-cell prolymphocytic leukemia with CAMPATH-1H, in Blood, vol. 98, n. 6, settembre 2001, pp. 1721–6, DOI:10.1182/blood.V98.6.1721, PMID 11535503. URL consultato il 29 novembre 2014 (archiviato dall'url originale il 28 marzo 2020).

ebscohost.com

web.ebscohost.com

Leukemia, su web.ebscohost.com, Columbia Electronic Encyclopedia, 6th Edition. URL consultato il 4 novembre 2011.

educom.it

Educom srl, http://www.educom.it/, Il Dolore « Capire la malattia | Comitato Maria Letizia Verga, su Comitato Maria Letizia Verga. URL consultato il 23 dicembre 2017.

jmmlfoundation.org

(EN) Research Study at UC San Francisco, su jmmlfoundation.org, The JMML (Juvenile Myelomonocytic Leukemia) Foundation. URL consultato l'11 giugno 2015 (archiviato l'8 maggio 2015).

leukemia-lymphoma.org

"Leukemia Facts & Statistics." The Leukemia & Lymphoma Society. Retrieved 2009-07-02.

lls.org

Childhood Blood Cancers | The Leukemia & Lymphoma Society Archiviato il 5 settembre 2012 in Internet Archive.

medscape.com

Patients with Chronic Myelogenous Leukemia Continue to Do Well on Imatinib at 5-Year Follow-Up Medscape Medical News 2006.
Valbuena JR, Herling M, Admirand JH, Padula A, Jones D, Medeiros LJ, T-cell prolymphocytic leukemia involving extramedullary sites, in American Journal of Clinical Pathology, vol. 123, n. 3, marzo 2005, pp. 456–64, DOI:10.1309/93P4-2RNG-5XBG-3KBE, PMID 15716243.

moffitt.org

Matutes, Estella. (1998) "T-cell prolymphocytic leukemia, a rare variant of mature post-thymic T-cell leukemias, has distinct clinical and laboratory characteristics and a poor prognosis." Archiviato l'11 febbraio 2009 in Internet Archive. Cancer Control Journal Volume 5 Number 1.

nih.gov

ncbi.nlm.nih.gov

JW Vardiman, J Thiele, DA Arber, RD Brunning, MJ Borowitz, A Porwit, NL Harris, MM Le Beau, E Hellström-Lindberg, A Tefferi e CD Bloomfield, The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes., in Blood, vol. 114, n. 5, 30 luglio 2009, pp. 937–51, DOI:10.1182/blood-2009-03-209262, PMID 19357394.
Alecsandru Ioan Baba, Cornel Cătoi, Comparative oncology, Bucharest, The Publishing House of the Romanian Academy, 2007, p. Chapter 17, ISBN 973-27-1457-3.
JJ Hutter, Childhood leukemia., in Pediatrics in review / American Academy of Pediatrics, vol. 31, n. 6, Jun 2010, pp. 234–41, DOI:10.1542/pir.31-6-234, PMID 20516235.
R Lozano, M, K, S, K, V, J, T, R, SY, M, HR, LM, KG, C, LM, S, DH, ML, EJ, D, K, B, A, G, F, I, S, C e M0, Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010, in Lancet, vol. 380, n. 9859, 15 dicembre 2012, pp. 2095–128, DOI:10.1016/S0140-6736(12)61728-0, PMID 23245604.
Joseph Wiemels, Perspectives on the Causes of Childhood Leukemia, in Chemico-biological interactions, vol. 196, n. 3, 5 aprile 2012, DOI:10.1016/j.cbi.2012.01.007. URL consultato il 23 dicembre 2017.
Colvin G. A., Elfenbein G. J., The latest treatment advances for acute myelogenous leukemia, in Medicine and Health, Rhode Island, vol. 86, n. 8, 2003, pp. 243–6, PMID 14582219.
Else, M., Ruchlemer, R., Osuji, N., Long remissions in hairy cell leukemia with purine analogs: a report of 219 patients with a median follow-up of 12.5 years, in Cancer, vol. 104, n. 11, 2005, pp. 2442–8, DOI:10.1002/cncr.21447, PMID 16245328.
Valbuena JR, Herling M, Admirand JH, Padula A, Jones D, Medeiros LJ, T-cell prolymphocytic leukemia involving extramedullary sites, in American Journal of Clinical Pathology, vol. 123, n. 3, marzo 2005, pp. 456–64, DOI:10.1309/93P4-2RNG-5XBG-3KBE, PMID 15716243.
Eichhorst BF, Busch R, Hopfinger G, Pasold R, Hensel M, Steinbrecher C, Siehl S, Jäger U, Bergmann M, Stilgenbauer S, Schweighofer C, Wendtner CM, Döhner H, Brittinger G, Emmerich B, Hallek M, German CLL Study Group, Fludarabine plus cyclophosphamide versus fludarabine alone in first-line therapy of younger patients with chronic lymphocytic leukemia, in Blood, vol. 107, n. 3, 2006, pp. 885–91, DOI:10.1182/blood-2005-06-2395, PMID 16219797.
Gribben JG, Stem cell transplantation in chronic lymphocytic leukemia, in Biol. Blood Marrow Transplant., vol. 15, 1 Suppl, gennaio 2008, pp. 53–8, DOI:10.1016/j.bbmt.2008.10.022, PMC 2668540, PMID 19147079.
Fausel C, Targeted chronic myeloid leukemia therapy: seeking a cure (PDF), in J Manag Care Pharm, vol. 13, 8 Suppl A, ottobre 2007, pp. 8–12, PMID 17970609. URL consultato il 29 novembre 2014 (archiviato dall'url originale il 28 maggio 2008).
Dearden CE, Matutes E, Cazin B, High remission rate in T-cell prolymphocytic leukemia with CAMPATH-1H, in Blood, vol. 98, n. 6, settembre 2001, pp. 1721–6, DOI:10.1182/blood.V98.6.1721, PMID 11535503. URL consultato il 29 novembre 2014 (archiviato dall'url originale il 28 marzo 2020).
Colvin GA, Elfenbein GJ, The latest treatment advances for acute myelogenous leukemia, in Med Health R I, vol. 86, n. 8, 2003, pp. 243–6, PMID 14582219.

novartisoncology.com

Novartis, su novartisoncology.com.

oadoi.org

JW Vardiman, J Thiele, DA Arber, RD Brunning, MJ Borowitz, A Porwit, NL Harris, MM Le Beau, E Hellström-Lindberg, A Tefferi e CD Bloomfield, The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes., in Blood, vol. 114, n. 5, 30 luglio 2009, pp. 937–51, DOI:10.1182/blood-2009-03-209262, PMID 19357394.
JJ Hutter, Childhood leukemia., in Pediatrics in review / American Academy of Pediatrics, vol. 31, n. 6, Jun 2010, pp. 234–41, DOI:10.1542/pir.31-6-234, PMID 20516235.
R Lozano, M, K, S, K, V, J, T, R, SY, M, HR, LM, KG, C, LM, S, DH, ML, EJ, D, K, B, A, G, F, I, S, C e M0, Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010, in Lancet, vol. 380, n. 9859, 15 dicembre 2012, pp. 2095–128, DOI:10.1016/S0140-6736(12)61728-0, PMID 23245604.
Else, M., Ruchlemer, R., Osuji, N., Long remissions in hairy cell leukemia with purine analogs: a report of 219 patients with a median follow-up of 12.5 years, in Cancer, vol. 104, n. 11, 2005, pp. 2442–8, DOI:10.1002/cncr.21447, PMID 16245328.
Eichhorst BF, Busch R, Hopfinger G, Pasold R, Hensel M, Steinbrecher C, Siehl S, Jäger U, Bergmann M, Stilgenbauer S, Schweighofer C, Wendtner CM, Döhner H, Brittinger G, Emmerich B, Hallek M, German CLL Study Group, Fludarabine plus cyclophosphamide versus fludarabine alone in first-line therapy of younger patients with chronic lymphocytic leukemia, in Blood, vol. 107, n. 3, 2006, pp. 885–91, DOI:10.1182/blood-2005-06-2395, PMID 16219797.

web.archive.org

Margie Patlak, Targeting Leukemia: From Bench to Bedside (PDF), su Breakthroughs in Bioscience, The Federation of American Societies for Experimental Biology. URL consultato il 20 maggio 2010 (archiviato dall'url originale il 26 luglio 2011).
Childhood Blood Cancers | The Leukemia & Lymphoma Society Archiviato il 5 settembre 2012 in Internet Archive.
Facts 2012 from The Leukemia & Lymphoma Society, su lls.org. URL consultato il 24 settembre 2014 (archiviato dall'url originale il 14 ottobre 2012).
Updated Results of Tyrosine Kinase Inhibitors in CML Archiviato il 29 dicembre 2007 in Internet Archive. ASCO 2006 Conference Summaries.
Matutes, Estella. (1998) "T-cell prolymphocytic leukemia, a rare variant of mature post-thymic T-cell leukemias, has distinct clinical and laboratory characteristics and a poor prognosis." Archiviato l'11 febbraio 2009 in Internet Archive. Cancer Control Journal Volume 5 Number 1.
(EN) How is Leukemia Diagnosed?, su cancer.org, American Cancer Society. URL consultato il 29 dicembre 2015 (archiviato dall'url originale il 23 dicembre 2007).
Fausel C, Targeted chronic myeloid leukemia therapy: seeking a cure (PDF), in J Manag Care Pharm, vol. 13, 8 Suppl A, ottobre 2007, pp. 8–12, PMID 17970609. URL consultato il 29 novembre 2014 (archiviato dall'url originale il 28 maggio 2008).
Cladribine in a weekly versus daily schedule for untreated active hairy cell leukemia: final report from the Polish Adult Leukemia Group (PALG) of a prospective, randomized, multicenter trial – Robak et al. 109 (9): 3672 – Blood, su bloodjournal.hematologylibrary.org. URL consultato il 10 settembre 2007 (archiviato dall'url originale il 29 settembre 2007).
Filgrastim for Cladribine-Induced Neutropenic Fever in Patients With Hairy Cell Leukemia – Saven et al. 93 (8): 2471 – Blood, su bloodjournal.hematologylibrary.org. URL consultato il 10 settembre 2007 (archiviato dall'url originale il 21 settembre 2007).
Dearden CE, Matutes E, Cazin B, High remission rate in T-cell prolymphocytic leukemia with CAMPATH-1H, in Blood, vol. 98, n. 6, settembre 2001, pp. 1721–6, DOI:10.1182/blood.V98.6.1721, PMID 11535503. URL consultato il 29 novembre 2014 (archiviato dall'url originale il 28 marzo 2020).
(EN) Treatment, su jmmlfoundation.org, The JMML Foundation. URL consultato il 29 dicembre 2015 (archiviato dall'url originale il 28 ottobre 2008).
(EN) Research Study at UC San Francisco, su jmmlfoundation.org, The JMML (Juvenile Myelomonocytic Leukemia) Foundation. URL consultato l'11 giugno 2015 (archiviato l'8 maggio 2015).

who.int

WHO Disease and injury country estimates, su World Health Organization, 2009. URL consultato l'11 novembre 2009.
Mathers, Colin D, Cynthia Boschi-Pinto, Alan D Lopez and Christopher JL Murray, Cancer incidence, mortality and survival by site for 14 regions of the world (PDF), in Global Programme on Evidence for Health Policy Discussion Paper No. 13, World Health Organization, 2001.